ATE283483T1 - Tumorenspezifisches p450 protein - Google Patents
Tumorenspezifisches p450 proteinInfo
- Publication number
- ATE283483T1 ATE283483T1 AT96931897T AT96931897T ATE283483T1 AT E283483 T1 ATE283483 T1 AT E283483T1 AT 96931897 T AT96931897 T AT 96931897T AT 96931897 T AT96931897 T AT 96931897T AT E283483 T1 ATE283483 T1 AT E283483T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- sample
- prepared sample
- detectable
- antibody
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/14—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen (1.14.14)
- C12Y114/14001—Unspecific monooxygenase (1.14.14.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/90245—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9519490.8A GB9519490D0 (en) | 1995-09-25 | 1995-09-25 | Use of a cytochrome P450 enzyme in tumour cells as a marker and target |
| PCT/GB1996/002368 WO1997012246A1 (en) | 1995-09-25 | 1996-09-25 | Tumour-specific p450 protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE283483T1 true ATE283483T1 (de) | 2004-12-15 |
Family
ID=10781203
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96931897T ATE283483T1 (de) | 1995-09-25 | 1996-09-25 | Tumorenspezifisches p450 protein |
| AT04019264T ATE491951T1 (de) | 1995-09-25 | 1996-09-25 | Tumorenspezifisches p450 protein |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04019264T ATE491951T1 (de) | 1995-09-25 | 1996-09-25 | Tumorenspezifisches p450 protein |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US6242203B1 (de) |
| EP (2) | EP1475639B1 (de) |
| JP (2) | JP3755897B2 (de) |
| AT (2) | ATE283483T1 (de) |
| AU (1) | AU7090396A (de) |
| DE (2) | DE69638310D1 (de) |
| ES (2) | ES2358106T3 (de) |
| GB (1) | GB9519490D0 (de) |
| WO (1) | WO1997012246A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19804372A1 (de) * | 1998-02-04 | 1999-08-05 | Michael W Dr Dr Dahm | Verfahren zur quantitativen Bestimmung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits |
| JP4642226B2 (ja) | 1998-02-06 | 2011-03-02 | デ モントフォート ユニヴァーシティ | ヒドロキシル化により活性化されたプロドラッグ |
| GB2334256A (en) | 1998-02-12 | 1999-08-18 | Univ Montfort | Hydroxylation activated prodrugs |
| US6623960B1 (en) * | 1999-02-12 | 2003-09-23 | The United States Of America As Represented By The Department Of Health And Human Services | Agents that bind to and inhibit human cytochrome P450 2C8, 2C9, 2C18 and 2C19 |
| GB9906380D0 (en) * | 1999-03-19 | 1999-05-12 | Melvin William T | Monoclonal antibodies specific for cypibi |
| WO2001035810A2 (en) * | 1999-11-15 | 2001-05-25 | Dana-Farber Cancer Institute, Inc. | Cancer immunotherapy and diagnosis using cytochrome p450 1b1 |
| GB0002835D0 (en) * | 2000-02-09 | 2000-03-29 | Melvin William T | Drug resistance in cancer |
| GB0007401D0 (en) | 2000-03-27 | 2000-05-17 | Cancer Res Campaign Tech | Substituted chalcones as therapeeutic compounds |
| US7241742B2 (en) | 2000-10-31 | 2007-07-10 | Mgi Pharma Biologics, Inc. | CYP1B1 nucleic acids and methods of use |
| US7385023B1 (en) | 2000-11-15 | 2008-06-10 | Trustees Of Boston University | Cancer immunotherapy and diagnosis using cytochrome P450 1B1 |
| EP1408960B1 (de) | 2001-02-22 | 2006-05-31 | School Of Pharmacy, University Of London | Benz-indol- und benzo-chinolin-derivate als prodrugs zur tumorbehandlung |
| ES2299560T3 (es) | 2001-02-22 | 2008-06-01 | University Of Bradford | Derivados de pirrolindol y de pirroloquinolina como profarmacos para el tratamiento de tumores. |
| JP2005512532A (ja) * | 2001-08-03 | 2005-05-12 | ディヴァーサ コーポレイション | P450酵素、それらをコードした核酸及びそれらの作製と使用 |
| GB0123780D0 (en) | 2001-10-03 | 2001-11-21 | Cancer Res Ventures Ltd | Substituted chalcones as therapeutic agents |
| GB0123777D0 (en) | 2001-10-03 | 2001-11-21 | Cancer Res Ventures Ltd | Substituted chalcones as therapeutic agents |
| MX2010003371A (es) | 2007-09-28 | 2010-05-05 | Intrexon Corp | Constructos interruptores genicos terapeuticos y biorreactores para la expresion de moleculas bioterapeuticas y usos de los mismos. |
| GB0803071D0 (en) * | 2008-02-20 | 2008-03-26 | Care Technologies Inc | Cancer detection methods and techniques |
| WO2009153131A1 (en) * | 2008-05-28 | 2009-12-23 | Basf Se | Means and methods for assessing liver enzyme induction |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2640976B1 (de) | 1988-12-22 | 1994-10-28 | Roussel Uclaf | |
| DK0569367T3 (da) * | 1991-01-15 | 1998-10-07 | Biotie Therapies Oy | Detektering af syndecanindhold i biologiske materialer, såsom væv og kropsvæsker, som indikationer på maligne transformatio |
| DE4309344A1 (de) | 1993-03-23 | 1994-09-29 | Gerhard Prof Dr Eisenbrand | Antineoplastische Mittel mit verstärkter Wirksamkeit |
-
1995
- 1995-09-25 GB GBGB9519490.8A patent/GB9519490D0/en active Pending
-
1996
- 1996-09-25 ES ES04019264T patent/ES2358106T3/es not_active Expired - Lifetime
- 1996-09-25 DE DE69638310T patent/DE69638310D1/de not_active Expired - Lifetime
- 1996-09-25 AU AU70903/96A patent/AU7090396A/en not_active Abandoned
- 1996-09-25 EP EP04019264A patent/EP1475639B1/de not_active Expired - Lifetime
- 1996-09-25 JP JP51321797A patent/JP3755897B2/ja not_active Expired - Lifetime
- 1996-09-25 US US09/043,814 patent/US6242203B1/en not_active Expired - Lifetime
- 1996-09-25 AT AT96931897T patent/ATE283483T1/de not_active IP Right Cessation
- 1996-09-25 AT AT04019264T patent/ATE491951T1/de not_active IP Right Cessation
- 1996-09-25 ES ES96931897T patent/ES2233977T3/es not_active Expired - Lifetime
- 1996-09-25 DE DE69633935T patent/DE69633935T2/de not_active Expired - Lifetime
- 1996-09-25 EP EP96931897A patent/EP0856157B1/de not_active Expired - Lifetime
- 1996-09-25 WO PCT/GB1996/002368 patent/WO1997012246A1/en not_active Ceased
-
2001
- 2001-06-04 US US09/874,166 patent/US20020052013A1/en not_active Abandoned
-
2002
- 2002-09-23 US US10/252,850 patent/US20030087408A1/en not_active Abandoned
-
2005
- 2005-07-01 JP JP2005193412A patent/JP4463155B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006034290A (ja) | 2006-02-09 |
| US20030087408A1 (en) | 2003-05-08 |
| DE69633935D1 (de) | 2004-12-30 |
| EP0856157B1 (de) | 2004-11-24 |
| GB9519490D0 (en) | 1995-11-29 |
| ES2358106T3 (es) | 2011-05-05 |
| ATE491951T1 (de) | 2011-01-15 |
| WO1997012246A1 (en) | 1997-04-03 |
| EP1475639A3 (de) | 2004-12-08 |
| EP0856157A1 (de) | 1998-08-05 |
| JP4463155B2 (ja) | 2010-05-12 |
| DE69638310D1 (de) | 2011-01-27 |
| ES2233977T3 (es) | 2005-06-16 |
| DE69633935T2 (de) | 2005-12-22 |
| AU7090396A (en) | 1997-04-17 |
| EP1475639B1 (de) | 2010-12-15 |
| US20020052013A1 (en) | 2002-05-02 |
| EP1475639A2 (de) | 2004-11-10 |
| JPH11512818A (ja) | 1999-11-02 |
| US6242203B1 (en) | 2001-06-05 |
| JP3755897B2 (ja) | 2006-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE283483T1 (de) | Tumorenspezifisches p450 protein | |
| AU2001253079A1 (en) | Methods, compositions and kits for the detection and monitoring of breast cancer | |
| WO2000004149A3 (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
| WO2001025272A3 (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
| MXPA02000192A (es) | Composiciones y metodos para la terapia y diagnostico de cancer de pulmon. | |
| WO2000060076A3 (en) | Compositions for the treatment and diagnosis of breast cancer and methods for their use | |
| WO1998010069A3 (en) | E25a protein, methods for production and use thereof | |
| WO2001034802A3 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| WO2001096388A8 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| EP1035215A3 (de) | Verfahren und Sondenset zur Erkennung von Krebs | |
| WO2001079286A3 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| DE69907156D1 (de) | Krebsbehandlung | |
| AU3568289A (en) | Detection of neu gene expression and products | |
| WO2000060077A3 (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use | |
| WO2000037643A3 (en) | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use | |
| WO2000052165A3 (en) | Compositions and methods for breast cancer therapy and diagnosis | |
| WO2002031209A3 (en) | Genes related to development of refractory prostate cancer | |
| AU7868300A (en) | Prostate cancer marker proteins | |
| AU4623599A (en) | Method for diagnosing an adenocarcinoma or a benign prostate pathology | |
| AU2001291911A1 (en) | Novel antibody, immunoassay and method for prostate cancer detection | |
| WO2001057207A3 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
| WO2002072752A3 (en) | Forms of prostate specific antigens and methods for their detection | |
| WO2001096389A3 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| WO2001090154A3 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
| YU5002A (sh) | Jedinjenja i postupci za lečenje i dijagnozu raka pluća |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |